Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Absorption and Excretion of Radioactively Tagged Dextroamphetamine Sulfate From a Sustained-Release Preparation

Absorption and Excretion of Radioactively Tagged Dextroamphetamine Sulfate From a... This study was undertaken to test the reliability of a sustained-release dosage form of dextroamphetamine sulfate. We tagged the drug with the radioactive carbon atom and gave four dosage regimens to 16 subjects following an incomplete block crossover design. The plasma and urine data obtained showed that the 15-mg sustained-release dosage form tested performed in a way comparable to 5 mg given three times each day, that it released its drug over a prolonged period, and that it was equivalent to other 15-mg regimens in the amount of drug made available for absorption. On the basis of these findings, we can say that the sustainedrelease dosage form tested is a reliable way to administer dextroamphetamine sulfate. The tests described herein, and tests of similar complexity, are becoming a more and more essential part of the evaluation of such dosage forms. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Absorption and Excretion of Radioactively Tagged Dextroamphetamine Sulfate From a Sustained-Release Preparation

Loading next page...
 
/lp/american-medical-association/absorption-and-excretion-of-radioactively-tagged-dextroamphetamine-1J0UJEJgsq
Publisher
American Medical Association
Copyright
Copyright © 1965 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1965.03090240037010
Publisher site
See Article on Publisher Site

Abstract

This study was undertaken to test the reliability of a sustained-release dosage form of dextroamphetamine sulfate. We tagged the drug with the radioactive carbon atom and gave four dosage regimens to 16 subjects following an incomplete block crossover design. The plasma and urine data obtained showed that the 15-mg sustained-release dosage form tested performed in a way comparable to 5 mg given three times each day, that it released its drug over a prolonged period, and that it was equivalent to other 15-mg regimens in the amount of drug made available for absorption. On the basis of these findings, we can say that the sustainedrelease dosage form tested is a reliable way to administer dextroamphetamine sulfate. The tests described herein, and tests of similar complexity, are becoming a more and more essential part of the evaluation of such dosage forms.

Journal

JAMAAmerican Medical Association

Published: Dec 13, 1965

There are no references for this article.